Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor.

Molecular Cancer Therapeutics
Sudeep BanerjeePartha Ray

Abstract

Gastrointestinal stromal tumor (GIST), the most common sarcoma, is characterized by KIT protein overexpression, and tumors are frequently driven by oncogenic KIT mutations. Targeted inhibition of KIT revolutionized GIST therapy and ushered in the era of precision medicine for the treatment of solid malignancies. Here, we present the first use of a KIT-specific DNA aptamer for targeted labeling of GIST. We found that an anti-KIT DNA aptamer bound cells in a KIT-dependent manner and was highly specific for GIST cell labeling in vitro Functionally, the KIT aptamer bound extracellular KIT in a manner similar to KIT mAb staining, and was trafficked intracellularly in vitro The KIT aptamer bound dissociated primary human GIST cells in a mutation agnostic manner such that tumors with KIT and PDGFRA mutations were labeled. In addition, the KIT aptamer specifically labeled intact human GIST tissue ex vivo, as well as peritoneal xenografts in mice with high sensitivity. These results represent the first use of an aptamer-based method for targeted detection of GIST in vitro and in vivo.

References

May 15, 1975·International Journal of Cancer. Journal International Du Cancer·M LieberG Todaro
Aug 30, 1990·Nature·A D Ellington, J W Szostak
Dec 1, 1991·British Journal of Cancer·C M BartonR C Williamson
May 1, 1994·Scandinavian Journal of Immunology·G NilssonL Hellman
Apr 7, 2000·Carcinogenesis·K F RobyP F Terranova
May 11, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Takahiro TaguchiKazunari Yuri
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Nov 18, 2011·Nature Reviews. Cancer·Christopher L CorlessMichael C Heinrich
Feb 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Badreddin EdrisMatt van de Rijn
Apr 9, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Partha RayRebecca Smock Woodruff
Aug 15, 2013·Annals of Surgical Oncology·Cristina A MetildiJason K Sicklick
Oct 8, 2013·Hematology/oncology Clinics of North America·Christine M BarnettMichael C Heinrich
Oct 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrey V ReshetnyakJoseph Schlessinger
Oct 4, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Grace L MaJason K Sicklick
Feb 5, 2015·Biotechnology Journal·Eric KowarzRolf Marschalek
Dec 13, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J Martin-BrotoR González-Cámpora
May 10, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Maha AlkhuziemJason K Sicklick
Apr 5, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lawrence L'ItalienSi Tuen Lee-Hoeflich
May 17, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tinya AbramsSiew C Schleyer
Aug 1, 2019·Journal of Translational Medicine·Sudeep BanerjeeJason K Sicklick

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved